Type | Public | |
Founded | 2008 | |
HQ | South San Francisco, CA, US | Map |
Website | cytomx.com | |
Employee Ratings |
USD | |
---|---|
Revenue (Q1, 2021) | 16.0m |
Net income (Q1, 2021) | (15.6m) |
EBIT (Q1, 2021) | (15.6m) |
Market capitalization (24-Jun-2022) | 124.0m |
Closing stock price (24-Jun-2022) | 1.9 |
Cash (31-Mar-2021) | 329.7m |
EV | (181.6m) |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.9m | 2.2m | 3.1m | 3.5m | 11.7m | 8.8m | 24.1m | 14.2m | 21.3m | 12.5m | 29.5m | 9.0m | 10.7m | 49.6m | 16.6m | 17.8m | 16.0m |
General and administrative expense | 4.1m | 5.0m | 4.6m | 5.0m | 5.7m | 6.0m | 6.2m | 7.4m | 9.0m | 8.1m | 9.7m | 9.4m | 8.5m | 9.6m | 8.7m | 8.6m | 9.2m |
R&D expense | 9.2m | 13.4m | 12.7m | 13.3m | 14.6m | 28.1m | 28.9m | 22.5m | 25.6m | 27.5m | 36.4m | 30.8m | 28.0m | 42.8m | 24.1m | 24.0m | 22.4m |
Operating expense total | 13.2m | 18.4m | 17.4m | 18.4m | 20.3m | 34.1m | 35.2m | 29.8m | 34.6m | 35.7m | 46.1m | 40.2m | 36.4m | 52.4m | 32.7m | 32.7m | 31.6m |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 36.2m | 67.9m | 62.4m | 59.8m | 85.7m | 272.9m | 284.2m | 142.2m | 132.9m | 259.8m | 190.4m | 149.4m | 164.6m | 143.3m | 291.4m | 176.8m | 329.7m |
Accounts Receivable | 406.0k | 316.0k | 285.0k | 240.0k | 213.0k | 158.0k | 40.2m | 81.0k | 25.1m | 56.0k | 44.0k | 10.0m | 7.0k | 130.0m | 206.0k | 543.0k | 756.0k |
Prepaid Expenses | 878.0k | 3.4m | 3.4m | 4.4m | 4.1m | 4.6m | 4.8m | 5.5m | 6.4m | 7.9m | 8.4m | 7.5m | 9.1m | 9.1m | 6.9m | 5.6m | 5.5m |
Current Assets | 115.1m | 184.5m | 199.6m | 183.3m | 166.9m | 340.7m | 376.4m | 367.0m | 366.7m | 472.5m | 405.1m | 366.7m | 334.8m | 400.1m | 366.6m | 340.3m | 400.0m |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (23.9m) | (16.0m) | (30.2m) | (44.9m) | (8.3m) | (33.5m) | (43.7m) | (15.5m) | (28.9m) | (52.4m) | (14.1m) | (43.1m) | (66.8m) | 12.2m | (3.5m) | (18.2m) | (15.6m) |
Depreciation and Amortization | 877.0k | 355.0k | 800.0k | 1.2m | 395.0k | 764.0k | 1.2m | 412.0k | 875.0k | 1.4m | 653.0k | 1.3m | 109.0k | 36.0k | 72.0k | 109.0k | 36.0k |
Accounts Payable | 749.0k | 246.0k | (3.2m) | (4.1m) | (2.8m) | 79.0k | (3.5m) | 1.1m | (429.0k) | 2.8m | 5.2m | 3.0k | 152.0k | 52.0k | 579.0k | (270.0k) | (292.0k) |
Cash From Operating Activities | (19.2m) | (5.5m) | 10.2m | (4.0m) | (19.1m) | 154.1m | 148.4m | (14.6m) | (41.2m) | (46.8m) | (39.0m) | (87.7m) | (111.0m) | (49.7m) | 47.4m | 22.7m | (29.9m) |
USD | Q3, 2015 |
---|---|
Financial Leverage | -1.2 x |
FY, 2016 | |
---|---|
Patents (Foreign) | 4 |
Patents (US) | 13 |
Patents Pending | 144 |
Phase I Trials Products | 1 |
CytomX Therapeutics has 970 Twitter Followers. The number of followers has increased 0.4% quarter over quarter
225
Tweets
126
Following
970
Followers
3
Tweets last 30 days
0
Avg. likes per Tweet
0%
Tweets with engagement
When was CytomX Therapeutics founded?
CytomX Therapeutics was founded in 2008.
Who are CytomX Therapeutics key executives?
CytomX Therapeutics's key executives are Sean A. McCarthy, Amy C. Peterson and Carlos Campoy.
How many employees does CytomX Therapeutics have?
CytomX Therapeutics has 158 employees.
What is CytomX Therapeutics revenue?
Latest CytomX Therapeutics annual revenue is $100.4 m.
What is CytomX Therapeutics revenue per employee?
Latest CytomX Therapeutics revenue per employee is $635.2 k.
Who are CytomX Therapeutics competitors?
Competitors of CytomX Therapeutics include Stingray Therapeutics, Forbius and SQZ Biotech.
Where is CytomX Therapeutics headquarters?
CytomX Therapeutics headquarters is located at 151 Oyster Point Blvd #400, South San Francisco.
Where are CytomX Therapeutics offices?
CytomX Therapeutics has an office in South San Francisco.
How many offices does CytomX Therapeutics have?
CytomX Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies